Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus
Keyword(s):
Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners, increases satiety, and delays gastric emptying. Liraglutide, unlike metformin and insulin, is not approved for use in the pediatric population. We report the successful off-label use of liraglutide in an obese, 16 year old Caucasian female with type 2 diabetes mellitus.
2007 ◽
Vol 74
(5)
◽
pp. 338-343
◽
2021 ◽
Vol 64
(6)
◽
pp. 432-437
2018 ◽
Vol 12
(4)
◽
pp. 202-209
◽
Keyword(s):
2019 ◽
Vol 149
◽
pp. 78-88
◽
Keyword(s):